Arcadia Biosciences (RKDA) Inventory (2014 - 2025)

Arcadia Biosciences has reported Inventory for 12 years, with the latest figure at $1.2 million in Q4 2025.

• For the quarter ending Q4 2025, Inventory rose 34.07% year-over-year to $1.2 million; the trailing twelve-month figure through Dec 2025 stood at $1.2 million (up 34.07% YoY), and the FY2025 full-year result was $1.2 million, up 34.07% from the prior year.
• Inventory for Q4 2025 stood at $1.2 million, down from $1.5 million in the prior quarter.
• The five-year high for Inventory was $5.4 million in Q3 2021, with the low at $835000.0 in Q3 2024.
• Historically, Inventory has averaged $2.4 million across 5 years, with a median of $2.5 million in 2022.
• Annual changes were most pronounced in 2021 — Inventory soared 200.75% — and 2024, when it plunged 69.09%.
• Arcadia Biosciences' Inventory stood at $4.4 million in 2021, then tumbled by 47.64% to $2.3 million in 2022, then slumped by 63.94% to $837000.0 in 2023, then grew by 8.0% to $904000.0 in 2024, then jumped by 34.07% to $1.2 million in 2025.
• The last three Inventory figures came in at $1.2 million (Q4 2025), $1.5 million (Q3 2025), and $1.5 million (Q2 2025), per Business Quant data.